Amgen, Watson to Hit the Biosimilar Road Together
By Mari Serebrov
Wednesday, December 21, 2011
Watson Pharmaceuticals Inc. has signed on to ride shotgun as Amgen Inc. prepares to hit the biosimilar road.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.